Distribution of & # 39; information leaflets on safety & use & # 39; on the note of the vaccine and the yellowing of the cholera vaccine

[충청매일=디지털뉴스팀] The Korea Food and Drug Administration (KFDA) introduced the "Safe Use Guide" in the country's public health centers and medical facilities for vaccination targets against yellow fever vaccine and cholera vaccine, The company said.

This fact sheet provides information on vaccines that can prevent yellow fever and cholera during summer travel, so that people can enjoy a safe and enjoyable holiday.

Yellow fever is a disease caused by mosquito bites when bitten by mosquitoes in Africa, Central America and South America by seafood contaminated with cholera excrement. The infection is a high incidence in Africa and Southeast Asia.

The instructions for the safe use of the yellow fever vaccine and the cholera vaccine are as follows: ▲ Vaccination subject ▲ Vaccination precautions ▲ Countermeasures in case of abnormal cases ▲ Frequently investigation and response.

The yellow fever vaccine is recommended when one travels to areas dangerous for yellow fever such as Africa and that it can be inoculated to children or adults over the 9 months.

However, infants, chickens, eggs and vaccine components less than 6 months old should not be inoculated if they have been hypersensitive to anaphylactic reactions such as anaphylaxis.

It is recommended that vaccination is not necessary because the vaccine can achieve permanent immunity once vaccinated, but high-risk groups such as the elderly may require revaccination.

The cholera vaccine is recommended to determine whether or not it is appropriate to vaccinate given the cholera outbreak situation and the level of hygiene of travel sites in the country. and may be inoculated to children or adults over 2 years of age. It is recommended to vaccinate 3-year-olds 3 times.

However, if hypersensitivity reactions have occurred prior to oral cholera vaccination, the formaldehyde or vaccine components should not be inoculated if they are hypersensitive.

A pharmacy official said, "We will continue to provide the necessary information so that consumers can get vaccines properly and know in the future."

In addition, if a serious allergic reaction develops after vaccination, or if the abnormal case persists or persists, seek immediate medical attention and receive medical treatment. In case of abnormal cases, please contact Korean Agency for Health Security Management (1644-6223), Online (www.drugsafe.or.kr) or email ([email protected]). "

For more information, visit the KFDA website, the KFDA Disease Control Headquarters and the KFDA website. For a list of related agencies, including vaccines, visit the website. www.cdc.go.kr. kr).